Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - AGILE THERAPEUTICS INC | agrx-20201231ex32240dde3.htm |
| EX-32.1 - EX-32.1 - AGILE THERAPEUTICS INC | agrx-20201231ex3215e2282.htm |
| EX-31.2 - EX-31.2 - AGILE THERAPEUTICS INC | agrx-20201231ex3125a3071.htm |
| EX-31.1 - EX-31.1 - AGILE THERAPEUTICS INC | agrx-20201231ex311f7edb9.htm |
| EX-10.13 - EX-10.13 - AGILE THERAPEUTICS INC | agrx-20201231ex101359d56.htm |
| EX-10.11 - EX-10.11 - AGILE THERAPEUTICS INC | agrx-20201231ex101139d1e.htm |
| EX-4.4 - EX-4.4 - AGILE THERAPEUTICS INC | agrx-20201231ex440027f39.htm |
| 10-K - 10-K - AGILE THERAPEUTICS INC | agrx-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
(1) Registration Statement (Form S-8 No. 333-199441), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
(2) Registration Statement (Form S-8 No. 333-205116), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
(3) Registration Statement (Form S-8 No. 333-210045), pertaining to Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
(4) Registration Statement (Form S-8 No. 333-217807), pertaining to Agile Therapeutics Inc. 2014 Incentive Compensation Plan,
(5) Registration Statement (Form S-8 No. 333-228151), pertaining to Agile Therapeutics, Inc. Amended and Restated 2014 Incentive Compensation Plan,
(6) Registration Statement (Form S-8 No. 333-232989) pertaining to Agile Therapeutics, Inc. Amended and Restated 2014 Incentive Compensation Plan (filed on August 2, 2019), and
(7)Registration Statement (Form S-3 No. 333-249273) of Agile Therapeutics, Inc.
of our report dated March 1, 2021, with respect to the financial statements of Agile Therapeutics, Inc., included in this Annual Report (Form 10-K) of Agile Therapeutics, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Iselin, New Jersey
March 1, 2021